Annexin Pharmaceuticals is a public company, listed on NASDAQ First North in Stockholm, Sweden, since April 19th 2017.
- Short name on First North: ANNX
- ISIN-code: SE0009664196
- The shares are administrated by Euroclear Sweden AB
English